drugset / Trial / NCT03784495
Melatonin Plus Aminoacids for Sarcopenic Elderly
RandomizedParallel-groupQuadruple-blindTreatment
Summary
To evaluate the effectiveness of melatonin and essential aminoacid supplementation on body composition, protein metabolism, strength and inflammation. The investigators performed a Randomized controlled parallel groups preliminary trial in 159 elderly sarcopenic people (42/117 men/women) assigned to 4 groups: isocaloric placebo (P, n=44), melatonin (M, 1 mg/daily, n=42,), essential aminoacids (eAA 4 g/daily, n=40) or eAA plus melatonin (eAAM, 4 g eAA and 1 mg melatonin/daily, n= 30). The period of intervention was 4 weeks. Data from body composition (DXA), strength (handgrip test) and biochemical parameters for the assessment of protein metabolism (albumin) and inflammation (PRC) were collected at baseline and after the 4-week intervention
Timeline
- Start
- 2014-01-01
- Primary completion
- 2014-12-31
- Completion
- 2015-06-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Essential Aminoacids | Unknown | 4 g | — |
| Subject | Melatonin | Small molecule | 1 mg | — |